Point prevalence and motor function of children and adolescents with cerebral palsy in Scandinavia and Scotland: a CP-North study.

Autor: Hollung SJ; The Cerebral Palsy Registry of Norway, Vestfold Hospital Trust, Tønsberg, Norway., Hägglund G; Orthopedics, Department of Clinical Sciences, Skåne University Hospital, Lund University, Lund, Sweden., Gaston MS; Royal Hospital for Sick Children, Edinburgh, UK., Seid AK; Centre for Alcohol and Drug Research, Aarhus University, Aarhus, Denmark., Lydersen S; Regional Centre for Child and Youth Mental Health and Child Welfare, Department of Mental Health, Norwegian University of Science and Technology, Trondheim, Norway., Alriksson-Schmidt AI; Orthopedics, Department of Clinical Sciences, Skåne University Hospital, Lund University, Lund, Sweden., Andersen GL; The Cerebral Palsy Registry of Norway, Vestfold Hospital Trust, Tønsberg, Norway.
Jazyk: angličtina
Zdroj: Developmental medicine and child neurology [Dev Med Child Neurol] 2021 Jun; Vol. 63 (6), pp. 721-728. Date of Electronic Publication: 2021 Jan 05.
DOI: 10.1111/dmcn.14764
Abstrakt: Aim: To describe the point prevalence of cerebral palsy (CP) and distribution of gross and fine motor function in individuals registered in a CP-North surveillance programme.
Method: Aggregate data of individuals with CP aged 6 to 19 years, sex, CP subtype, and gross and fine motor function levels were collected from each programme. Overall and age-specific point prevalence of CP was calculated for each programme using 95% confidence intervals. Logistic regression was used to estimate prevalence and CP subtypes with age as the covariate variable. Pearson χ 2 tests were used to compare the distributions of CP subtypes, Gross Motor Function Classification System (GMFCS) levels, and Manual Ability Classification System (MACS) levels by age and between programmes.
Results: Among 3 759 138 individuals residing in Scandinavia and Scotland, 8278 had a diagnosis of CP (57-59% were males). The overall point prevalence of CP ranged from 2.13 to 2.32 per 1000 residents. Age-specific prevalence in each programme varied with the exception of Denmark. While the proportions of bilateral spastic CP were similar between programmes, there were variations in all other CP subtypes and in GMFCS and MACS levels.
Interpretation: While the results of this study may reflect real differences in CP populations between countries, they may not be clinically relevant. The variations may be attributable to differences in the year when each programme was first established, different data collection methods, and country-specific governmental policies.
(© 2021 The Authors. Developmental Medicine & Child Neurology published by John Wiley & Sons Ltd on behalf of Mac Keith Press.)
Databáze: MEDLINE
Externí odkaz: